Extracorporeal shock wave lithotripsy is a non-invasive treatment most commonly used to treat kidney stone and biliary calculi. Lithotripter supplies a high-intensity acoustic pulse to crush the stone with minimal collateral damage to normal tissue and the shock waves break the stone into smaller pieces. Thus, there is an increasing demand for shock wave lithotripsy worldwide, owing to its important characteristic, such as non-invasiveness, reduced pain, recovery time, and reduced hospital stay. Moreover, the success rate of extracorporeal shock wave lithotripsy is higher for people with smaller stones, such as less than 1 centimeter.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/513
Extracorporeal shock wave lithotripsy is most commonly used to remove stones from kidney, gallbladder, ureter, salivary duct, or salivary gland. It is also most effective in treatment of non-obstructing renal calculi.
Increasing prevalence of kidney stones ureter stones around the world is expected to augment the growth of the global extracorporeal shock wave lithotripsy market over the forecast period. For instance, according to the 2012 National Health and Nutrition Examination Survey, the prevalence of kidney stones was found to be higher in women than in men.
Moreover, increasing prevalence of obesity and rise in diabetic patient population worldwide is expected to drive growth of the global market. Furthermore, availability of technologically advanced equipment and rampant development of healthcare infrastructure is expected to fuel the growth of the global extracorporeal shock wave lithotripsy market.
North America, Europe, and Asia-pacific are expected to witness robust growth in the global extracorporeal shock wave lithotripsy market due to the increasing incidence of kidney stones, increased government investment, and improvement in healthcare facilities in these regions. For instance, as per the Centers for Disease Control and Prevention, around 4.9 million people in the United States were diagnosed with kidney disease in 2015.
Key players active in the global extracorporeal shock wave lithotripsy market are Siemens AG, GE Healthcare, Lumenis LTD, C.R. Bard Inc., and Boston Scientific Corporation.
Request PDF Brochure with Latest Insights @
In March 2020, Extracorporeal Shock Wave Lithotripsy was launched at M Yunus Regional Hospital in Benkulu, Indonesia to provide proper and improvised health services.
In March 2019, Dornier MedTech announced the launch of the new OptiVision technology for the Dornier Delta III (an extracorporeal shock wave lithotripsy) at German Urology Congress (DGU) 2019 in Hamburg.
In July 2017, Dornier MedTech America received FDA clearance to market the Delta III, the most advanced kidney stone treatment, lithotripter.
In September 2018, Stroz Medical and Seimens Healthlineers teamed up to develop powerful extracorporeal shock wave lithotripsy technology to remove stones from the urinary tract.
- Electrohydraulic Technique
- Electromagnetic Technique
- Piezoelectric Technique
- Kidney Stones
- Uretic Stones
- Pancreatic Stones
- Salivary Stones
By End User:
- North America
- Latin America
- Asia Pacific
- Middle East
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/513
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027